Back to search

Treatment of refractory autoimmune diseases with ablative immunotherapy

Data up to Jan 2025

Published2003
Citations20
References37

Total Citations Per Year

Abstract

References (37)

CD4+CD25+ suppressor T cells: more questions than answers

2002 • 2,202 citations

Transcriptional Mechanisms Underlying Lymphocyte Tolerance

2002 • 658 citations

An open study of B lymphocyte depletion in systemic lupus erythematosus

2002 • 573 citations

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura

2001 • 553 citations

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

1999 • 467 citations

Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion

2002 • 345 citations

The CAMPATH‐1 antigen (CDw52)

1990 • 334 citations

Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease

2001 • 286 citations

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children

2003 • 285 citations

Hematopoietic stem cell transplantation for multiple sclerosis

2002 • 263 citations

Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis

1996 • 251 citations

Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma

1997 • 249 citations

High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis

2003 • 223 citations

Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis

1994 • 186 citations

Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS

2001 • 169 citations

Autologous stem cell transplantation in progressive multiple sclerosis--an interim analysis of efficacy.

2000 • 168 citations

Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration

1997 • 157 citations

A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia.

2000 • 144 citations

Anti‐CD20 monoclonal antibody (Rituximab) for life‐threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus

2002 • 135 citations

Hematopoietic stem cell transplantation for severe and refractory lupus

2002 • 124 citations

High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis

2000 • 113 citations

Favourable response to therapy with the anti‐CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease

2001 • 111 citations

Rituxan in the Treatment of Cold Agglutinin Disease

1998 • 98 citations

Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia

2002 • 97 citations

High-dose cyclophosphamide with autologous lymphocyte–depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia

2002 • 96 citations

Thymic Requirement for Clonal Deletion During T Cell Development

1989 • 95 citations

CAMPATH-1H in multiple sclerosis

1996 • 53 citations

»Katastrophaler SLE« mit Rosai-Dorfman-Sinushistiozytose

2001 • 47 citations

["Catastrophic systemic lupus erythematosus" with Rosai-Dorfman sinus histiocytosis. Successful treatment with anti-CD20/rutuximab].

2001 • 44 citations

Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.

1996 • 35 citations

Monotherapy with Rituximab Induces Rapid Remission of Recurrent Cold Agglutinin-Mediated Hemolytic Anemia in a Patient with Indolent Lympho-Plasmacytic Lymphoma

2001 • 33 citations

CD40 Ligand Functions Non-Cell Autonomously to Promote Deletion of Self-Reactive Thymocytes

2002 • 32 citations

The T-cell repertoire available for recognition of self-antigens

2001 • 32 citations

Changes in autoimmune thyroid disease following allogeneic bone marrow transplantation

2001 • 29 citations

Intense immune suppression for systemic lupus--the role of hematopoietic stem cells.

2000 • 23 citations

The use of high dose immunoablative therapy with hematopoietic stem cell support therapy in the treatment of severe autoimmune diseases

2002 • 8 citations

A Mind of Its Own-Tourette's Syndrome

1996 • 1 citations

Cited By (0)

Loading...
Treatment of refractory autoimmune diseases with ablative immunotherapy (2003) – Autoimmunity Reviews | Metascience Observatory Explorer